Palatin Clinical Site 168 — Omaha, Nebraska

Palatin Clinical Site 168 is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Palatin Clinical Site 168 has participated in 1 clinical trials.

Therapeutic areas: Hypoactive Sexual Desire Disorder.

Sponsors: Palatin Technologies, Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Palatin Clinical Site 168?

Palatin Clinical Site 168 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Palatin Clinical Site 168 conducted?

Palatin Clinical Site 168 has 1 clinical trials on record. Their work covers Hypoactive Sexual Desire Disorder.

Is Palatin Clinical Site 168 accredited by Crixeo Health?

Palatin Clinical Site 168 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Palatin Clinical Site 168?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.